Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Lambert

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
The Journal of Surgical Research|May 7, 2022
Is Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy Still Indicated in Patients With Extraperitoneal Disease?Eliza W Beal, J C Chen, Alex Kim, et al.
Frontiers in Oncology|January 24, 2025
Long term outcomes associated with the use of perioperative systemic chemotherapy on low grade appendiceal mucinous neoplasms with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapySamantha M Ruff, Gyulnara Kasumova, Manoj Palavalli, et al.
The Journal of Surgical Research|September 4, 2023
Prediction of Early Recurrence Following CRS/HIPEC in Patients With Disseminated Appendiceal CancerGopika SenthilKumar, Jennifer Merrill, Ugwuji N Maduekwe, et al.
Pharmaceutics|December 23, 2022
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [<sup>153</sup>Sm]Sm-DOTA-TATEKoen Vermeulen, Michiel Van de Voorde, Charlotte Segers, et al.
Frontiers in Medicine|October 29, 2021
Efficient Production of High Specific Activity Thulium-167 at Paul Scherrer Institute and CERN-MEDICISReinhard Heinke, Eric Chevallay, Katerina Chrysalidis, et al.
Circulation. Heart Failure|March 31, 2025
Mucopolysaccharidosis Type IIIA Presenting as Hypertrophic CardiomyopathyFilippo Pinto E Vairo, Jeffrey B Geske, Ravinder J Singh, et al.
The Journal of Surgical Research|October 8, 2023
Weekend Discharge Is Not Associated With Increased Readmission After Hyperthermic Intraperitoneal ChemotherapyIsabella Florissi, Shannon N Radomski, Benjamin Shou, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2024
Target Development towards First Production of High-Molar- Activity <sup>44g</sup>Sc and <sup>47</sup>Sc by Mass Separation at CERN-MEDICISEdgars Mamis, Charlotte Duchemin, Valentina Berlin, et al.
Frontiers in Medicine|May 10, 2021
Production of Mass-Separated Erbium-169 Towards the First Preclinical <i>in vitro</i> InvestigationsZeynep Talip, Francesca Borgna, Cristina Müller, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 3, 2020
Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced recovery after surgery (ERAS®) Society Recommendations - Part I: Preoperative and intraoperative managementMartin Hübner, Shigeki Kusamura, Laurent Villeneuve, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
The Journal of Surgical Research|May 7, 2022
Is Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy Still Indicated in Patients With Extraperitoneal Disease?Eliza W Beal, J C Chen, Alex Kim, et al.
Frontiers in Oncology|January 24, 2025
Long term outcomes associated with the use of perioperative systemic chemotherapy on low grade appendiceal mucinous neoplasms with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapySamantha M Ruff, Gyulnara Kasumova, Manoj Palavalli, et al.
The Journal of Surgical Research|September 4, 2023
Prediction of Early Recurrence Following CRS/HIPEC in Patients With Disseminated Appendiceal CancerGopika SenthilKumar, Jennifer Merrill, Ugwuji N Maduekwe, et al.
Pharmaceutics|December 23, 2022
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [<sup>153</sup>Sm]Sm-DOTA-TATEKoen Vermeulen, Michiel Van de Voorde, Charlotte Segers, et al.
Frontiers in Medicine|October 29, 2021
Efficient Production of High Specific Activity Thulium-167 at Paul Scherrer Institute and CERN-MEDICISReinhard Heinke, Eric Chevallay, Katerina Chrysalidis, et al.
Circulation. Heart Failure|March 31, 2025
Mucopolysaccharidosis Type IIIA Presenting as Hypertrophic CardiomyopathyFilippo Pinto E Vairo, Jeffrey B Geske, Ravinder J Singh, et al.
The Journal of Surgical Research|October 8, 2023
Weekend Discharge Is Not Associated With Increased Readmission After Hyperthermic Intraperitoneal ChemotherapyIsabella Florissi, Shannon N Radomski, Benjamin Shou, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2024
Target Development towards First Production of High-Molar- Activity <sup>44g</sup>Sc and <sup>47</sup>Sc by Mass Separation at CERN-MEDICISEdgars Mamis, Charlotte Duchemin, Valentina Berlin, et al.
Frontiers in Medicine|May 10, 2021
Production of Mass-Separated Erbium-169 Towards the First Preclinical <i>in vitro</i> InvestigationsZeynep Talip, Francesca Borgna, Cristina Müller, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 3, 2020
Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced recovery after surgery (ERAS®) Society Recommendations - Part I: Preoperative and intraoperative managementMartin Hübner, Shigeki Kusamura, Laurent Villeneuve, et al.
Pageof 7